Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular PreventionUdo Hoffmann, Robert T. OʼDonnell, Kathleen Melbourne et al.|JAMA Network Open|2021Cited by 82
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE TrialPamela S. Douglas, Steven Grinspoon, Triin Umbleja et al.|Clinical Infectious Diseases|2021Cited by 41
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE TrialCarl J. Fichtenbaum, Dushyantha Jayaweera, Heather J. Ribaudo et al.|The Journal of Infectious Diseases|2020Cited by 13
HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral TherapyMabel Toribio, Michael L. Fitzgerald, Min Hi Park et al.|The Journal of Clinical Endocrinology & Metabolism|2017Cited by 12
Effects of Integrase Inhibitor–Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIVMabel Toribio, Markella V. Zanni, Tricia H. Burdo et al.|Open Forum Infectious Diseases|2020Cited by 11